Objective To study the usefulness of model for end-stage liver disease (MELD) in clinical practice and the role of artificial liver support system(ALSS) in end-stage liver disease.

• 摘要目的通过观察终末期肝病模型(MELD)在重型肝炎患者人工肝治疗后3个月时的预后分析，探讨其在临床应用的价值及对人工肝支持系统的治疗效果。